Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
      • Neuroimmunology: To Sense and Protect
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

CD8+ Cell Depletion Accelerates HIV-1 Immunopathology in Humanized Mice

Santhi Gorantla, Edward Makarov, Jennifer Finke-Dwyer, Catherine L. Gebhart, William Domm, Stephen Dewhurst, Howard E. Gendelman and Larisa Y. Poluektova
J Immunol June 15, 2010, 184 (12) 7082-7091; DOI: https://doi.org/10.4049/jimmunol.1000438
Santhi Gorantla
*Department of Pharmacology and Experimental Neuroscience and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edward Makarov
*Department of Pharmacology and Experimental Neuroscience and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jennifer Finke-Dwyer
*Department of Pharmacology and Experimental Neuroscience and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Catherine L. Gebhart
†Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William Domm
‡Department of Microbiology and Immunology, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen Dewhurst
‡Department of Microbiology and Immunology, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Howard E. Gendelman
*Department of Pharmacology and Experimental Neuroscience and
†Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Larisa Y. Poluektova
*Department of Pharmacology and Experimental Neuroscience and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF + SI
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Additional Files
  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    Percentages of human cells in spleen. Human cells in spleens of uninfected and HIV-1–infected mice were determined by FACS at the time of sacrifice. Individual numbers (percentages) per animal, ratio of CD4/CD8, cells and medians are shown. The p values between groups analyzed by nonparametric Mann-Whitney U test are shown.

  • FIGURE 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2.

    Peripheral blood profiles in HIV-1–infected humanized NSG mice. To determine the dynamics of viral replication and immune cell numbers in peripheral blood, mice were bled biweekly starting 3 wk after HIV-1 infection. Only three animals were frequently bled; because facial vein bleeding with short intervals was affecting animal behavior, we did not follow the same procedure for all of the animals.

  • FIGURE 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3.

    Profile of IFN-γ and IL-2 cytokine-secreting human cells in mouse spleens at 5 wk postinfection. FACS plots are shown from three infected mice and one uninfected mouse. The numbers of cells producing cytokines in response to in vitro stimulation by HIV-1 gag and envelope peptide pools were determined by ICS, and the results were compared with those in nonstimulated cells. Splenocytes were enriched for human CD45+ cells using the magnetic bead separation method and stimulated with peptide pools for 18 h with brefeldin A included during the last 6 h. CD8+ (blue) and CD4+ (red) T cells producing IFN-γ and IL-2 are shown, and the numbers represent percentages of cells positive for each cytokine. The hierarchy followed for gating was CD45 → CD3 → CD8 or CD4 → IFN-γ or IL-2. IFN-γ and IL-2 double-positive cells shown are from respective gates indicated by arrows.

  • FIGURE 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 4.

    Effect of CD8+ cell depletion on peripheral viral load and T cell numbers. A, Two uninfected/CD8+ cell-depleted (upper panels, m306 and m303) and two HIV-1–infected (m304-305) are shown. Dynamics of viral load in peripheral blood were determined by the Amplicor kit, and the detection limit was 1750 copies per milliliter. The numbers of human CD4+ and CD8+ T cells were analyzed by FACS, and the percentages shown are from human CD45 gated cells. CD8+ cell depletion was performed at 5 wk postinfection. B, Representative flow cytometric plots from #305 showing human CD4+ and CD8+ cells in peripheral blood before and after 1 and 3 wk of depletion. The inset at 3 wk postdepletion shows CD3+CD8+ cells reappearing in circulation. Similar recovery of CD3+CD8+ cells in spleen collected at the end point (3 wk after depletion) is also shown. All of the animals were reconstituted with the same sample of cord blood-derived HSCs.

  • FIGURE 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 5.

    Summary of changes in peripheral blood viral load in HIV-1–infected animals following CD8+ cell depletion. A, In HIV-1–infected control animals, viral load was analyzed at different time-points starting at 2 wk postinfection (black squares, n = 10). Plasma from the animals depleted 2 wk postinfection were analyzed for viral load at 2 wk (bleed) and 4 wk (sacrifice) postinfection (open squares, n = 4). In animals that were depleted 5–7 wk postinfection, viral load was analyzed until sacrifice (i.e., 8–9 wk postinfection) (open circles, n = 7). Dashed line represents the assay detection limit of <1750 viral copies per milliliter. The level of significance was *p < 0.05 as determined by Wilcoxon test. Data are presented as geometrical means and standard deviations. B and C, Values are compared with that of nondepleted HIV-1–infected animals at 4 wk postinfection (B) and 7–9 wk postinfection (C) time points for statistical analyses, and the level of significance was determined by Mann-Whitney U test. Data are presented for individual mice as geometrical means.

  • FIGURE 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 6.

    Immunohistochemical staining analyses of lymphoid tissue in CD8+ cell depletion. Immunohistochemical staining of cervical lymph nodes from uninfected and HIV-1–infected/CD8+ cell-depleted animals. Serial sections of paraffin-embedded tissue were stained for human cell markers, CD8, HIV-1 p24, CD79α, HLA-DR, and Ki-67. Images were captured under an objective lens at original magnification ×10. Lymph nodes from HIV-1–infected animals were analyzed at 2 wk following CD8+ cell depletion performed at 4 wk postinfection. Commonly seen HIV-1 p24 Ag-positive cells and syncytia, altered B cell distribution, and increased activation (HLA-DR) were detected.

  • FIGURE 7.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 7.

    Thymus morphology in uninfected and HIV-1–infected/CD8+ cell-depleted animals. A, Representative sections of paraffin-embedded thymi tissues were stained for human cell markers. Thymi from one uninfected control mouse and two HIV-1–infected mice (collected at 1 wk after CD8+ depletion and 8 wk following virus infection) are shown. Top panels, original magnification ×20; all other panels, original magnification ×400. Control thymus was populated by CD45RO+, CD4/CD8 double-positive cells. A small portion of the cortical area was occupied by CD4 single-positive cells. In CD8+ cell-depleted thymi, the numbers of double-positive cells were reduced, and the proliferative activity was increased as detected by Ki-67 staining. HLA-DR–positive cells with dendritic cell morphology were present in all of the thymi along with claudin-3–positive mouse epithelial cells (data not shown). B, Representative FACS plots of thymic cells from an uninfected control and HIV-1–infected/CD8+ cell-depleted mice. Compared to the control thymus, CD8+ cell depletion resulted in a decrease in CD4/CD8 double-positive cells and a profound decrease in CD8+ cells.

Tables

  • Figures
  • Additional Files
    • View popup
    Table I. Profiles of HIV-1 infected and CD8+ cell depleted animals
    Engraftment Parameters
    GroupsaAge (wk)Weeks PostinfectionbCD45+ (%, Spleen)IgM (μg/ml)IgG (μg/ml)HIV RNA Copies/mlc
    Uninfected control26.530.4103.4208.0
     n = 1423–363.8–50.5<3.1–962.0<7.8–402.0
    HIV-1–infected 291028.8168.093.5114,800
     n = 1526–365–133.1–72.918.0–1019.6<7.8–453.813,335–1,526,000
    HIV-1–infected CD8+ cell-depleted 29720.2154.270.1382,550
     n = 1225–334–93.1–52.648.4–523.0<7.8–856.724,745 to >35,000,000
    HIV-1–uninfected CD8+ cell-depleted339.4225.8175.3
     n = 729–353.1–80.6123.4–1005.1<7.8–576.3
    • ↵a End point data are shown as median and the range (minimal and maximal values).

    • ↵b Period of HIV-1 infection before the animals were euthanized.

    • ↵c Detection limit was 1750 copies/ml. Detection was performed using 20 μl plasma diluted to a total volume of 700 μl as a requirement for automated evaluation by Amplicor kit with detection limit of 50 copies/ml. Productive infection was confirmed by detection of HIV-1 p24-positive cells in lymphoid tissues.

    • View popup
    Table II. Dynamics of T cells and viral load in peripheral blood of HIV-1–infected mice with established infection with and without CD8+ cell depletion
    CD8 (%)aCD4 (%)VL (Copies/ml)VL (log10)
    Mouse No.BeforeAfterBeforeAfterΔ (%)BeforeAfterBeforeAfterΔ
    CD8+ cell depleted animalsb1041.204.90.5−89.8114,800454,5005.065.660.60
    1085.6010.12.7−73.35,7401,239,0003.766.092.33
    30411.40.925.612.3−51.9245,3501,225,0005.396.090.70
    30533.2045.911.6−74.78,435,00031,395,0006.937.500.57
    Nondepleted animalsc3482.2nd5.2nd187,25075,2505.274.88−0.40
    30210.77.252.413.3−74.68,050,000990,5006.916.00−0.91
    1694.421.97.44.1−45.0205,450455,0005.315.660.35
    14925.217.415.21.0−93.42,961,00062,6506.474.80−1.67
    15935.719.112.77.7−39.4409,50038,1505.614.58−1.03
    pd0.50.0140.4430.3430.2780.0320.4380.0160.008
    • ↵a Percentage of human cells in peripheral blood at the time of viral load analysis.

    • ↵b Mice were analyzed at 5–7 wk postinfection before CD8+ cell depletion and 2 wk after depletion.

    • ↵c Data from nondepleted mice represent the first detected peak of viremia (before) and 2 wk after.

    • ↵d p Values were determined by Mann-Whitney U test.

    • nd, no data.

Additional Files

  • Figures
  • Tables
  • Data Supplement

    Files in this Data Supplement:

    • Supplemental Table 1 (PDF, 32.8 Kb) - Characteristics of humanized animals (Table 1).
PreviousNext
Back to top

In this issue

The Journal of Immunology: 184 (12)
The Journal of Immunology
Vol. 184, Issue 12
15 Jun 2010
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Advertising (PDF)
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Immunology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
CD8+ Cell Depletion Accelerates HIV-1 Immunopathology in Humanized Mice
(Your Name) has forwarded a page to you from The Journal of Immunology
(Your Name) thought you would like to see this page from the The Journal of Immunology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
CD8+ Cell Depletion Accelerates HIV-1 Immunopathology in Humanized Mice
Santhi Gorantla, Edward Makarov, Jennifer Finke-Dwyer, Catherine L. Gebhart, William Domm, Stephen Dewhurst, Howard E. Gendelman, Larisa Y. Poluektova
The Journal of Immunology June 15, 2010, 184 (12) 7082-7091; DOI: 10.4049/jimmunol.1000438

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
CD8+ Cell Depletion Accelerates HIV-1 Immunopathology in Humanized Mice
Santhi Gorantla, Edward Makarov, Jennifer Finke-Dwyer, Catherine L. Gebhart, William Domm, Stephen Dewhurst, Howard E. Gendelman, Larisa Y. Poluektova
The Journal of Immunology June 15, 2010, 184 (12) 7082-7091; DOI: 10.4049/jimmunol.1000438
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Early Self-Regulatory Mechanisms Control the Magnitude of CD8+ T Cell Responses Against Liver Stages of Murine Malaria
  • Sublethal Hyperoxia Impairs Pulmonary Innate Immunity
  • Dependence of IL-4, IL-13, and Nematode-Induced Alterations in Murine Small Intestinal Smooth Muscle Contractility on Stat6 and Enteric Nerves
Show more HOST DEFENSE

Similar Articles

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • FAR 889
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2021 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606